AvidBiotics raises $1M for anti-infective drugs

November 7, 2007 | David P. Hamilton | Comments | |

See our story about this South San Francisco, Calif., biotech in Monday’s daily briefing at VentureBeat Life Sciences.

Next Story: Real estate site Trulia showing momentum; Is Zillow in trouble?
Previous Story: Aryx discounts IPO price, raises up to $58M for safer drugs

Bookmark and Share

Photo of David P. Hamilton

About the Author, David P. Hamilton

David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.